GSK Settles Zantac Cases After Claiming Popular Heartburn Drug Causes Cancer
Top line Pharmaceutical heavyweight GSK announced Wednesday that it has settled four U.S. lawsuits that claimed its popular heartburn drug Zantac caused cancer, averting a trial that was scheduled to begin in California on Wednesday. next month as it and other pharmaceutical companies struggle to navigate looming legal threats from discontinuing the drug. . GSK …